IMMUNOGENICITY OF INTRAVENOUS ASPARAGINASE ERWINIA CHRYSANTHEMI IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA OR LYMPHOBLASTIC LYMPHOMA

被引：0
|
作者：
Benson, B. [1 ]
Lu, Y. [2 ]
Eller, M. [3 ]
机构：
[1] Jazz Pharmaceut Inc, Clincial Dev, Palo Alto, CA USA
[2] Jazz Pharmaceut Inc, Biostat, Palo Alto, CA USA
[3] Jazz Pharmaceut Inc, Res & Clin Dev, Palo Alto, CA USA
来源：
PEDIATRIC BLOOD & CANCER | 2014年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-037
引用
收藏
页码：S262 / S262
页数：1
相关论文
共 50 条
  • [21] Activity and Toxicity of Intravenous Erwinia Asparaginase Following Allergy to E. coli-Derived Asparaginase in Children and Adolescents With Acute Lymphoblastic Leukemia
    Vrooman, Lynda M.
    Kirov, Ivan I.
    Dreyer, ZoAnn E.
    Kelly, Michael
    Hijiya, Nobuko
    Brown, Patrick
    Drachtman, Richard A.
    Messinger, Yoav H.
    Ritchey, A. Kim
    Hale, Gregory A.
    Maloney, Kelly
    Lu, Yuan
    Plourde, Paul V.
    Silverman, Lewis B.
    PEDIATRIC BLOOD & CANCER, 2016, 63 (02) : 228 - 233
  • [22] Venetoclax and Navitoclax in Pediatric Patients with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
    Rubnitz, Jeffrey E.
    Alexander, Thomas B.
    Laetsch, Theodore W.
    Khaw, Seong Lin
    Pullarkat, Vinod A.
    Opferman, Joseph T.
    Roberts, Kathryn G.
    Rosenwinkel, Lindsey
    Tong, Bo
    Pesko, John C.
    Badawi, Mohamed
    Vishwamitra, Deeksha
    Kim, Su Young
    Mullighan, Charles G.
    Lacayo, Norman J.
    BLOOD, 2020, 136
  • [23] Engineered asparaginase from Erwinia chrysanthemi enhances asparagine hydrolase activity and diminishes enzyme immunoreactivity - a new promise to treat acute lymphoblastic leukemia
    Costa, Iris Munhoz
    Moura, Debora Custodio
    Lima, Guilherme Meira
    Pessoa, Adalberto
    dos Santos, Camila Oresco
    de Oliveira, Marcos A.
    Monteiro, Gisele
    JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY, 2022, 97 (01) : 228 - 239
  • [24] Intravenous and Intramuscular Administration of Asparaginase in Paediatric Patients with Acute Lymphoblastic Leukemia: Treatment Patterns and Perceptions
    Bernard, C.
    Hall, M.
    Doede, T.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S107 - S107
  • [25] Intravenous and Intramuscular Administration of Asparaginase in Pediatric Patients with Acute Lymphoblastic Leukemia: Treatment Patterns and Perceptions
    Bernard, Celine
    Hall, Megan P.
    Doede, Tina
    BLOOD, 2015, 126 (23)
  • [26] L-asparaginase in the treatment of patients with acute lymphoblastic leukemia
    Egler, Rachel A.
    Ahuja, Sanjay P.
    Matloub, Yousif
    JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2016, 7 (02) : 62 - 71
  • [27] Asparaginase Toxicities Identification and management in patients with acute lymphoblastic leukemia
    Van Thu Huynh
    Bergeron, Sharon
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2017, 21 (05) : E248 - E259
  • [28] Asparaginase activity levels and monitoring in patients with acute lymphoblastic leukemia
    Salzer, Wanda
    Bostrom, Bruce
    Messinger, Yoav
    Perissinotti, Anthony J.
    Marini, Bernard
    LEUKEMIA & LYMPHOMA, 2018, 59 (08) : 1797 - 1806
  • [29] Pegylated E. coli Asparaginase Desensitization: An Effective and Feasible Option for Pediatric Patients with Acute Lymphoblastic Leukemia Who Have Developed Hypersensitivity to Pegaspargase in the Absence of Asparaginase Erwinia Chrysanthemi availability
    Verma, Anupam
    Chen, Karin
    Johnsen, Jacob
    Barnette, Phillip
    BLOOD, 2018, 132
  • [30] Peg-asparaginase for acute lymphoblastic leukemia
    Rytting, Michael
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2010, 10 (05) : 833 - 839
12345